Old Web
English
Sign In
Acemap
>
authorDetail
>
François Guilhot
François Guilhot
Novartis
Hematologic Response
Immunology
Medicine
Complete Hematologic Response
Phases of clinical research
2
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II Study of Oral Panobinostat (LBH589) in Accelerated Phase (AP) or Blast Crisis (BC) Chronic Myeloid Leukemia (CML) Patients Resistant to ≥2 BCR-ABL Tyrosine Kinase Inhibitors
2008
Blood
François Guilhot
Viviane Dubruille
Aleksander B. Skotnicki
Andrey Hellmann
Jila Shamsazar
Priscille Bourquelot
Muhammad Jalaluddin
Martha Li
Elisabetta Abruzzese
Luke Akard
Show All
Source
Cite
Save
Citations (5)
A Phase I/II Dose Escalating Study of Daunorubicin Combined with Imatinib Mesylate and Cytarabine as Induction Therapy for Chronic Myelogenous Leukaemia in Myeloid Blast Crisis. Preliminary Results of the AFR01 Trial.
2004
Blood
Philippe Rousselot
L. Legros
J. Guilhot
Mauricette Michallet
Francois-Xavier Mahon
Cecile Pautas
Denis Guyotat
Agnes Guerci
C. Berthou
Bernard Rio
Lydia Roy
Patrice Berthaud
François Guilhot
Show All
Source
Cite
Save
Citations (1)
1